<VariationArchive VariationID="30929" VariationName="NM_024592.5(SRD5A3):c.204dup (p.Phe69fs)" VariationType="Duplication" Accession="VCV000030929" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-11" DateCreated="2016-10-23" MostRecentSubmission="2024-03-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="39886" VariationID="30929">
      <GeneList>
        <Gene Symbol="SRD5A3" FullName="steroid 5 alpha-reductase 3" GeneID="79644" HGNC_ID="HGNC:25812" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>4q12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="55346242" stop="55373100" display_start="55346242" display_stop="55373100" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="56212387" stop="56239266" display_start="56212387" display_stop="56239266" Strand="+" />
          </Location>
          <OMIM>611715</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_024592.5(SRD5A3):c.204dup (p.Phe69fs)</Name>
      <CanonicalSPDI>NC_000004.12:55346538:CC:CCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>4q12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="55346538" stop="55346539" display_start="55346538" display_stop="55346539" variantLength="1" positionVCF="55346538" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="56212705" stop="56212706" display_start="56212705" display_stop="56212706" variantLength="1" positionVCF="56212705" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>F69fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.12" sequenceAccession="NC_000004" sequenceVersion="12" change="g.55346540dup" Assembly="GRCh38">
            <Expression>NC_000004.12:g.55346540dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_028230.1" sequenceAccession="NG_028230" sequenceVersion="1" change="g.5320dup">
            <Expression>NG_028230.1:g.5320dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.56212707dup" Assembly="GRCh37">
            <Expression>NC_000004.11:g.56212707dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024592.5" sequenceAccession="NM_024592" sequenceVersion="5" change="c.204dup" MANESelect="true">
            <Expression>NM_024592.5:c.204dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_078868.1" sequenceAccession="NP_078868" sequenceVersion="1" change="p.Phe69fs">
            <Expression>NP_078868.1:p.Phe69fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA352221" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="611715.0006" DB="OMIM" />
        <XRef Type="rs" ID="869320736" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 20700148 Fig. 1a to determine the location of this allele on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_024592.5(SRD5A3):c.204dup (p.Phe69fs) AND Kahrizi syndrome" Accession="RCV000023917" Version="10">
        <ClassifiedConditionList TraitSetID="7297">
          <ClassifiedCondition DB="MedGen" ID="C2675185">Kahrizi syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2011-01-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-10-23" MostRecentSubmission="2024-03-10">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18781183</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20700148</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7297" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2503" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MENTAL RETARDATION, CATARACT, COLOBOMA, AND KYPHOSIS, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="612713" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Kahrizi syndrome</ElementValue>
                <XRef ID="Kahrizi+syndrome/8702" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012991" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">KHRZ</ElementValue>
                <XRef Type="MIM" ID="612713" DB="OMIM" />
              </Symbol>
              <XRef ID="168972" DB="Orphanet" />
              <XRef ID="C2675185" DB="MedGen" />
              <XRef ID="MONDO:0012991" DB="MONDO" />
              <XRef Type="MIM" ID="612713" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="50464" SubmissionDate="2016-10-21" DateLastUpdated="2024-03-10" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="611715.0006_KAHRIZI SYNDROME" title="SRD5A3, 1-BP DUP, 203C_KAHRIZI SYNDROME" />
        <ClinVarAccession Accession="SCV000045208" DateUpdated="2024-03-10" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 sibs, born of consanguineous Iranian parents, with Kahrizi syndrome (KHRZ; 612713), previously reported by (Kahrizi et al., 2009), Kahrizi et al. (2011) identified a homozygous 1-bp duplication (203dupC) in exon 1 of the SRD5A3 gene, resulting in a frameshift and premature termination. Each unaffected parent and 2 unaffected sibs were heterozygous for the mutation, which was not found in 366 control chromosomes. RT-PCR analysis showed missing or reduced expression of the SRD5A3 gene in patient lymphoblastoid cells. The phenotype was characterized by mental retardation, cataracts, coloboma, and kyphosis. However, biochemical studies showed no clear abnormal transferrin mobility in routine testing for CDG. The mutation was identified by array-based exon enrichment and next-generation sequencing.</Attribute>
              <Citation>
                <ID Source="PubMed">18781183</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">20700148</ID>
              </Citation>
              <XRef DB="OMIM" ID="612713" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SRD5A3" />
          </GeneList>
          <Name>SRD5A3, 1-BP DUP, 203C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 203C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="611715.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">KAHRIZI SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="50464" TraitType="Disease" MappingType="Name" MappingValue="KAHRIZI SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C2675185" Name="Kahrizi syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>